Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Metagenomi Therapeutics, Inc. | 291,450 | reported | 01 Apr 2024 | tx 2+360,766 |
| FIVE PRIME THERAPEUTICS INC | 64,888 | reported | 01 Mar 2017 | tx 7+67,656−19,390 |
| Century Therapeutics, Inc. | 0 | reported | 03 Apr 2023 | tx 16+768,946−502,607 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 69,316 | 0.00 USD | |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 291,450 | 0.00 USD | deriv |
| 03 Apr 2023 | EXERCISE | Century Therapeutics, Inc. | 7,452 | 1.03 USD | |
| 03 Apr 2023 | EXERCISE | Century Therapeutics, Inc. | 7,452 | 0.00 USD | deriv |
| 23 Mar 2023 | SALE | Century Therapeutics, Inc. | 15,597 | 3.55 USD | |
| 23 Mar 2023 | EXERCISE | Century Therapeutics, Inc. | 220,930 | 1.03 USD | |
| 21 Mar 2023 | EXERCISE | Century Therapeutics, Inc. | 63,616 | 1.03 USD | |
| 21 Mar 2023 | SALE | Century Therapeutics, Inc. | 63,616 | 3.77 USD | |
| 22 Mar 2023 | EXERCISE | Century Therapeutics, Inc. | 65,698 | 1.03 USD | |
| 22 Mar 2023 | SALE | Century Therapeutics, Inc. | 65,698 | 3.72 USD | |
| 23 Mar 2023 | EXERCISE | Century Therapeutics, Inc. | 220,930 | 0.00 USD | deriv |
| 22 Mar 2023 | EXERCISE | Century Therapeutics, Inc. | 65,698 | 0.00 USD | deriv |
| 21 Mar 2023 | EXERCISE | Century Therapeutics, Inc. | 63,616 | 0.00 USD | deriv |
| 02 Feb 2023 | GRANT_AWARD | Century Therapeutics, Inc. | 21,875 | 0.00 USD | |
| 02 Feb 2023 | GRANT_AWARD | Century Therapeutics, Inc. | 21,875 | 0.00 USD | |
| 02 Feb 2023 | GRANT_AWARD | Century Therapeutics, Inc. | 131,250 | 0.00 USD | deriv |
| 02 Feb 2023 | GRANT_AWARD | Century Therapeutics, Inc. | 131,250 | 0.00 USD | deriv |
| 25 Jan 2022 | GRANT_AWARD | Century Therapeutics, Inc. | 105,000 | 0.00 USD | deriv |
| 01 Mar 2017 | TAX_WITHHOLDING | FIVE PRIME THERAPEUTICS INC | 18,084 | 44.77 USD | |
| 07 Feb 2017 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 7,031 | 0.00 USD | |
| 07 Feb 2017 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 5,625 | 0.00 USD | |
| 07 Feb 2017 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 25,000 | 0.00 USD | deriv |
| 03 Jan 2017 | TAX_WITHHOLDING | FIVE PRIME THERAPEUTICS INC | 1,306 | 48.60 USD | |
| 08 Sept 2016 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 5,000 | 0.00 USD | |
| 08 Sept 2016 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 25,000 | 0.00 USD | deriv |